World Health Organization
Avenue Appia 20
1211
Geneva 27
Tel: 00-41-22-791-21-11
Fax: +00-41-22-791-3111
Website: http://www.who.int/
Email: info@who.int
394 articles with World Health Organization
-
New data shows Zolgensma, Novartis’ gene therapy for spinal muscular atrophy, has the potential to be used presymptomatically in juveniles.
-
Performance Update on World Health Organisation SARS-CoV2 Serology Standards
6/15/2021
MedMira Inc. announces the World Health Organization SARS-CoV-2 serology standards testing results.
-
While several countries rely on Sinovac Biotech to end the pandemic, concerns regarding the shot’s efficacy continue to shroud the vaccine. Currently, it is the second most used vaccine worldwide.
-
The latest news in COVID-19 includes support for an investigation into the origins of the virus, a new naming system, and legal discussions of whether employers can mandate vaccination.
-
The White House has also called for an independent investigation and more information from China about the pandemic's origins.
-
The Francis Crick Institute and the Latvian Institute of Organic Synthesis developed a new compound that blocks the life cycle of the mosquito-borne parasite that causes malaria.
-
The disclosure comes the day before the WHO is expected to plan for the next phase of investigations into the origins of COVID-19.
-
X-Vax Technology is preparing to submit an IND application to the U.S. FDA for its experimental vaccine against Herpes simplex virus 1 and 2 (HSV-1 and -2).
-
Researchers are calling for a “paradigm shift” in indoor ventilation systems to combat COVID-19 and other airborne pathogens.
-
The report listed four scenarios in order of likelihood, with the top being from bats through another animal.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 23, 2021.
-
According to an interview with Soumya Swaminathan, the WHO's chief scientist, the new investigational COVID-19 vaccines rely on alternative technologies and systems of delivery. Some include oral and nasal administration, while others use skin patches.
-
Cochlear welcomes landmark WHO report calling on governments and societies to prioritize hearing health
3/3/2021
Cochlear has joined people with hearing loss, hearing care experts and advocates in welcoming the World Health Organization's landmark World Report on Hearing, which calls upon governments and societies to prioritize hearing health.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 2, 2021.
-
Non-Invasive Vagus Nerve Stimulation May Treat Migraine in Patients with COVID-19, According to Neurologist Stephen D. Silberstein, M.D.
2/16/2021
According to the World Health Organization, 13.6 percent of patients diagnosed with COVID-19 experienced a headache, often described as moderate to severe in intensity, many of which “may feel like a migraine attack.” Not only is headache one of the signs of the COVID-19 virus, it is also recognized as a lingering symptom long after the illness is over.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 16, 2021.
-
The origins of COVID-19 continue to be debated in the halls of government, and the findings from a recent investigation conducted by the World Health Organization are unlikely to change many minds as the world continues to grapple with the pandemic.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 9, 2021.
-
Sinovac Files for Conditional Market Authorization of COVID-19 Vaccine in China
2/3/2021
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that it has officially filed for conditional market authorization for CoronaVac, the COVID-19 vaccine, with China’s National Medical Products Administration.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 8, 2020.